0001004878-14-000282.txt : 20140723
0001004878-14-000282.hdr.sgml : 20140723
20140723113644
ACCESSION NUMBER: 0001004878-14-000282
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140722
ITEM INFORMATION: Submission of Matters to a Vote of Security Holders
FILED AS OF DATE: 20140723
DATE AS OF CHANGE: 20140723
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: 8-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 14988136
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
8-K
1
form8kitem507july-14.txt
8-K RE ANNUAL MEETING VOTES
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 22, 2014
CEL-SCI CORPORATION
--------------------------------------------
(Exact name of Registrant as specified in its charter)
Colorado 0-11503 84-0916344
-------------------- ------------------- -----------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
8229 Boone Boulevard, Suite 802
Vienna, Virginia 22182
------------------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (703) 506-9460
N/A
-----------------------------------------------
(Former name or former address if changed since last report)
Item 5.07. Submission of Matters to a Vote of Securities Holders.
The annual meeting of CEL-SCI's shareholders was held on July 22, 2014. At
the meeting the following persons were elected as directors for the upcoming
year:
Votes
------------------------------ Broker
Name For Against Non-Votes
Maximum de Clara 13,069,097 1,898,021 31,915,625
Geert R. Kersten 13,996,321 970,797 31,915,625
Alexander G. Esterhazy 13,168,170 1,798,948 31,915,625
Dr. C. Richard Kinsolving 13,180,494 1,786,624 31,915,625
Dr. Peter R. Young 13,126,604 1,840,514 31,915,625
At the meeting the following were ratified by CEL-SCI's shareholders:
(1) the adoption of CEL-SCI's 2014 Incentive Stock Bonus Plan;
(2) on an advisory basis, compensation of CEL-SCI's executive officers;
(3) on an advisory basis, the frequency of advisory votes on the
compensation of CEL-SCI's executive officers and
(4) ratification of the appointment of BDO USA, LLP as CEL-SCI's
independent registered public accounting firm for the fiscal year
ending September 30, 2014;
The following is a tabulation of votes cast with respect to proposals 1, 2
and 4:
Votes
------------------------------ Broker
Proposal For Against Abstain Non-Votes
(1) 11,006,338 3,624,806 336,004 31,915,625
(2) 11,749,271 2,904,851 313,026 31,915,625
(4) 45,055,277 774,221 1,053,275 0
The following is a tabulation of votes cast with respect to proposal 3:
Broker
1 Year 2 Years 3 Years Abstain Non-Votes
------ ------- ------- ------- ---------
3,451,175 806,908 9,405,323 1,303,742 31,915,625
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 23, 2014 CEL-SCI CORPORATION
By:/s/ Patricia B. Prichep
------------------------------------
Patricia B. Prichep,
Senior Vice President of Operations